genes of interest were annotated using Geneious R10 software (BioMatters, New Zealand).
201
Manual trimming and editing of terminally redundant contig ends generated circular plasmid 202 genomes. The complete plasmid sequence were visualized using plasmid mapping in CLC and 203 deposited in GenBank with prospective accession numbers. isolates was not detected in the transconjugants (Table 3 ). The plasmid pS27 from S.
260
Typhimurium var5-recovered from NC farm5 had the MDR pattern: AMP CHL FIS STR TET.
261
Unlike pS12, pS13, pS14, and pS15 isolated from transconjugants of S. Typhimurium var5-in AST, 14 AMR-encoding genes were tested using PCR-based method ( tetracycline resistance. In plasmids with streptomycin resistance, aadA1 and aadA2 were found.
273
The sul1 gene was the most prevalent among plasmids which were resistant to the antimicrobial 274 sulfisoxazole. Plasmid pS14 and pS15 did not test positive for any AMR genes which were 275 tested in this study. The resistance genotypes of all 14 plasmids were tabulated in Table 1 .
276
Plasmid Sequencing and Analysis. The incompatibility (Inc) group and resistance genes of 277 plasmid were confirmed using sequencing (Table 1) . Plasmid sequencing was able to identify the plasmids from different farms and serotypes (pS9, pS10, pS12, pS13, pS14, pS15, pS27; Table   280 1) were identical to another fully sequenced plasmid pSTY1-H2662 previously isolated from S.
281
Typhimurium from human stool (accession no. CP014980) (48). A class 1 integron was 282 identified in plasmid pS6-pS8 isolated from S. Worthington using in silico method. This integron 283 comprised of 5'conserved segment, variable part, and 3'conserved segment (Fig 1; pS7) . The sequences was created using Geneious R10 software (Fig 2) . At 70% similarity, the plasmids 290 from the same Salmonella donor were clustered together including pS6, pS7, pS8 (from S.
291
Worthington) and pS28, pS29 (from S. Ohio). The plasmid with distinct size, 100-kb pS9 and (Table 1) .
The aim of the study was to characterize the plasmids identified in different AMR Salmonella 301 serotypes isolated from commercial swine farms environment after land application of manure.
302
We also wanted to determine the plasmid role in the dissemination of AMR genes to other The plasmid R-pattern: Nalidixic acid (NAL) resistance was removed from NAL R E. coli JM109 transconjugant R-pattern. amoxicillin/clavulanic acid (AUG2; 1/0.5-32/16 μg/ml; breakpoint>32/16), ampicillin (AMP; 1-32 μg/ml; breakpoint>32), cefoxitin (FOX; 0.5-32 μg/ml; breakpoint>32), ceftriaxone (AXO; 0.25-64 μg/ml; breakpoint>4), chloramphenicol (CHL; 2-32 μg/ml; breakpoint>32), gentamicin (GEN; 0.25- b amoxicillin/clavulanic acid (AUG2; 1/0.5-32/16 μg/ml; breakpoint>32/16), ampicilin (AMP; 1-32 μg/ml; breakpoint>32), azithromycin (AZI; 0.12-16 μg/ml; breakpoint>32), cefoxitin (FOX; 0.5-32 μg/ml; breakpoint>32), ceftiofur (XNL; 0.12-8 μg/ml; breakpoint>8), ceftriaxone (AXO; 0.25-64 μg/ml; breakpoint>4), chloramphenicol (CHL; 2-32 μg/ml; breakpoint>32), ciprofloxacin (CIP; 0.015±4 μg/ml; breakpoint>4), gentamicin (GEN; 0.25-16 μg/ml; breakpoint>16), nalidixic acid (NAL; 0.5-32 μg/ml; breakpoint>32), streptomycin (STR; 32-64 μg/ml; breakpoint>32), sulfisoxazole (FIS; 16-256 μg/ml; breakpoint>512), trimetroprim/sulfamethoxazole (SXT; 0.12/2.38-4/76 μg/ml; breakpoint>4/76), and tetracycline (TET; 4-32 μg/ml; breakpoint>16)
Bold letters indicate the resistance of Salmonella isolates or transconjugants in each antimicrobial. 
